The paper describes how chemists made new metal‑selenium compounds using molybdenum, ruthenium and iron. It does not discuss the peptide selank or any health‑related effects, so it isn’t useful for biohackers looking for dosage or performance tips.

The salt elimination reactions of [NEt4][Mo(CSe)(CO)2(Tp*)] ([NEt4][2], Tp* = hydrotris(3,5-dimethylpyrazol-1-yl)borate) with a range of metal halide complexes (ClMLn) have been investigated as a possible route to isoselenocarbonyl complexes [Mo(CSeMLn)(CO)2(Tp*)]. Thus the reactions of [NEt4][2] with [RuCl(L)2(η-C5R5)] provide molybdenum-ruthenium derivatives [Mo{CSeRu(L)2(η-C5R5)}(CO)2(Tp*)] (L = PPh3, R = H 4, L = CO, R = Me 5), both of which were structurally characterised. The molybdenum-iron derivative [Mo{CSeFe(CO)2(η-C5H5)}(CO)2(Tp*)] (6) was obtained from [NEt4][2] and [FeCl(CO)2(η-C5H5)] however its formulation currently rests on spectroscopic and microanalytical data. The reaction of [NEt4][2] with [RuH(NCMe)(CO)2(PPh3)2]PF6 affords the structurally characterised hydrido-isoselenocarbonyl complex [Mo{CSeRuH(CO)2(PPh3)2}(CO)2(Tp*)] (7) with no indication of coupling of the hydride and selenocarbonyl ligand.